CVS Group PLC, a leading provider of integrated veterinary services in the UK, announced that Richard Gray, a Non-executive Director of the Company, purchased 1,600 ordinary shares of 0.2p each on 10 July 2024. This transaction increased Richard Gray's total interest in the Company to 7,600 Ordinary Shares, representing 0.011% of the total voting rights of the Company. The purchase was made on the open market and was disclosed in accordance with the UK Market Abuse Regulation.
The company's contacts for further information were provided, including CVS Group plc, Peel Hunt LLP, Berenberg, and Camarco. The notification and public disclosure of the transaction by persons discharging managerial responsibilities and persons closely associated with them were also detailed in the announcement.
The details of the transaction included the nature of the transaction (on-market purchase), the price (1,019.60 pence), the volume (1,600 shares), and the date of the transaction (10 July 2024). The notification provided comprehensive information in compliance with regulatory requirements.
This announcement provides transparency regarding the share dealings of a key figure within CVS Group PLC, offering insight into the company's internal activities and the confidence of its leadership in its future prospects.